Search results for “Metastatic renal cell cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 37 patents, we discovered top 15 key players by total patent application. Novartis Vaccines & Diagnostics, Inc., X4 Pharmaceuticals, Inc., Assistance Publique des Hôpitaux de Paris SA are dominant in this area. They take 64.86% of the total patent filing.
Novartis Vaccines & Diagnostics, Inc.
New Jersey, United States
Patent: 14
X4 Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 7
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 3
Ed Geistlich Söhne AG Für Chemische Industrie
ZURICH, Switzerland
Patent: 3
Institut National de la Santé et de la Recherche Médicale
France
Patent: 3
Resverlogix Corp.
Alberta, Canada
Patent: 2
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Immutep Ltd.
New South Wales, Australia
Patent: 1
Chiron Corp.
California, United States
Patent: 1
Beijing Eastern Biotech Co Ltd
Beijing Shi, China
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 10 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Assistance Publique des Hôpitaux de Paris SA, Institut National de la Santé et de la Recherche Médicale, Beth Israel Deaconess Medical Center, Inc. take 80.00% of patent filing during this period.
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 3
Institut National de la Santé et de la Recherche Médicale
France
Patent: 3
Beth Israel Deaconess Medical Center, Inc.
Massachusetts, United States
Patent: 2
Université de Paris
France
Patent: 2
X4 Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Regents of the University of California
California, United States
Patent: 1
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 10 patents in last 5 years, we discover 5 new entrants. Assistance Publique des Hôpitaux de Paris SA, Beth Israel Deaconess Medical Center, Inc., Université de Paris are the most active new entrants in this area.
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 3
Beth Israel Deaconess Medical Center, Inc.
Massachusetts, United States
Patent: 2
Université de Paris
France
Patent: 2
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 9 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Université de Paris
France
Patent: 2
University of Nice Sophia Antipolis
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: